M JAMES BARRETT Insider Trading $ADAP Adaptimmune Therapeutics PLC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for M JAMES BARRETT.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of M JAMES BARRETT. M JAMES BARRETT is 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and Director in PHARMION CORP ($PHRM) and Director in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and Director in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and Director in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Liquidia Technologies Inc ($LQDA) and Director in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and Director in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and Director in Clovis Oncology, Inc. ($CLVS) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Epizyme, Inc. ($EPZM) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Zosano Pharma Corp ($ZSAN) and Director in Senseonics Holdings, Inc. ($SENS) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Surface Oncology, Inc. ($SURF).

M JAMES BARRETT in Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of M JAMES BARRETT: 10% Owner
Holdings: 82,978,668 shares
Current Value: $375,893,366
Latest Transaction: Sep 10 2018
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of M JAMES BARRETT in Adaptimmune Therapeutics PLC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADAP, APPN, ARDM, ARDX, CRCM, CBIO, CERC, CLVS, EPZM, GLYC, HPTX, INHX, INWK, IOMI, ILIU, LIQDA, LOXO, MRSN, MULE, MYOG, PRTK, PHRM, RARX, RYTM, SENS, ROKA, SUPN, SURF, SYBX, TSRO, TCON, VTAE, VG, YMTX, ZSAN, ZHNE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 10 2018ADAPAdaptimmune Therap ...BARRETT M JAMES10% OwnerBuyP1.673,000,0005,000,10082,978,66880 M to 83 M (+3.75 %)
Mar 28 2018ADAPAdaptimmune Therap ...BARRETT M JAMES10% OwnerBuyP1.926,000,00011,500,20079,978,67274 M to 80 M (+8.11 %)
Mar 28 2018ADAPAdaptimmune Therap ...BARRETT M JAMES10% OwnerBuyP1.90571,1641,087,55373,978,67273.4 M to 74 M (+0.78 %)
Mar 23 2018ADAPAdaptimmune Therap ...BARRETT M JAMES10% OwnerBuyP1.95294,090572,35873,407,50873.1 M to 73.4 M (+0.40 %)
Mar 23 2018ADAPAdaptimmune Therap ...BARRETT M JAMES10% OwnerBuyP1.90869,5741,655,66973,113,41872.2 M to 73.1 M (+1.20 %)
Mar 23 2018ADAPAdaptimmune Therap ...BARRETT M JAMES10% OwnerBuyP1.81104,844189,82072,243,84472.1 M to 72.2 M (+0.15 %)
Mar 28 2017ADAPAdaptimmune Therap ...BARRETT M JAMES10% OwnerBuyP0.7012,870,0009,009,00072,139,00059.3 M to 72.1 M (+21.71 %)

Page:   1